Long-term outcomes of GD

Long-term outcomes of GD2
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma

In a phase 1 clinical trial open to accrual from 2004 to 2009, we treated children with neuroblastoma with Epstein–Barr virus (EBV)-specific T lymphocytes and CD3-activated T cells—each expressing chi…

Loading

Similar Posts